Focus Areas



The American Diabetes Association reports that diabetes affects over 29 million Americans. Over 347 million people worldwide have the disease, and millions more are considered pre-diabetic or insulin resistant. NC Research Campus scientists and doctors (below) are approaching the prevention and treatment of diabetes using novel nutritional approaches and new models of patient care. To the right, keep up with the latest journal articles and news about diabetes research at the NC Research Campus.


William Pilkington, DPA, directs tabarrus Health Alliance. As the local health authority for Cabarrus County where the NC Research Campus is located, CHA works directly with people in the community who have diabetes providing education, support and opportunities for free cooking and exercise classes.  Learn more about CHA.


The David H. Murdock Research Institute (DHMRI) has extensive experience working with large pharmaceutical partners and academic consortia assessing new therapeutic approaches and early detection of disease in both Type I and Type II diabetes. The DHMRI provides diabetes researchers biomarker, clinical chemistry and immunology analysis for both in vivo and in vitro models. Learn More


Slavko Komarnytsky, PhD, is an expert in metabolic biology and pharmacogenomics and an assistant professor with the NC State Plants for Human Health Institute. His research centers on how dietary bioactive components prevent chronic metabolic diseases and inflammation, with a specific emphasis on the pathological mechanisms of insulin resistance and muscle loss. Learn more.


Led by Mary Ann Lila, PhD, much of the research at the NC State University Plants for Human Health Institute examines the bioactive compounds in fruits and vegetables to unlock their curative potential, especially in regard to diabetes and other chronic diseases. Learn more.



Shengmin Sang, PhD, associate professor specializing in functional foods with the NCA&T Center for Post-Harvest Technologies, researches preventative and therapeutic measures for chronic diseases like cancer and diabetes by using metabolomics to identify dietary exposure markers and bioactive compounds. Learn more.

Zhang cropped

Qibin Zhang, PhD, co-director of the UNC Greensboro Center for Translational Biomedical Research, is an expert in biomedical research using mass spectrometry and other advanced instrumentation to study type 1 diabetes and proteins and lipids as biomarkers of disease progression. Learn more.



Comments are closed.